Marc was a pure scientist. Honest, direct, he was a man of his word. He was a hard worker and had a constant intellectual curiosity. Outside In 1981, he began his work on the mechanism of action of the anticancer drug cisplatin and new promising platinum based drugs, which was to be his main focus for the next nineteen years. By generating antibodies against platinated DNA he was able to quantify platinum adducts. Subsequently, he studied physico-chemical properties of platinated nucleic acids, the interactions between proteins and platinated DNA and the cross-linking of platinated oligonucleotides to nucleic acids. In addition to his well-known results on distortions in platinated DNA, he discovered that a very fine chemistry of some platinum adducts can be promoted by the double helix i) the formation of new adducts between cisplatin and intercalating drugs and their rearrangements ii) the rearrangement of the transplatin 1,3-ntrastrand cross-links into interstrand cross-links. Recently, this latter reaction was used to modulate gene expression as part as an antisense strategy which has been patented. Marc will not be able to pursue this promising research since the very disease he was trying to find a cure for unfortunately defeated him. 
